Acupuncture Reduces Severity of Hot Flashes in Breast Cancer: A Randomized Single-Blind Trial.

Hot flashes are one of the most disruptive side effects faced by breast cancer patients, often caused or worsened by hormone-blocking treatments. A clinical trial published in Holistic Nursing Practice explored whether traditional acupuncture could help reduce the severity of these episodes — and the results are encouraging.

In this randomized, single-blind study, 54 breast cancer patients who were experiencing more than 10 hot flashes per week were divided into two groups. One group received traditional Chinese medicine-based acupuncture (TA), while the other received a "sham" placebo version (SA) designed to mimic the real treatment without the same therapeutic effect. Participants rated their hot flash severity using a validated quality-of-life scale at the start of the study, after treatment, and again one month later.

The findings were striking. Women who received real acupuncture saw their hot flash severity scores drop by an average of 1.89 points — a statistically significant improvement. By contrast, the sham acupuncture group saw scores drop by just 0.16 points, essentially no meaningful change. Even more promising, the benefits in the real acupuncture group held up at the one-month follow-up, suggesting the relief wasn't just temporary.

What does this mean for you? If you are a breast cancer patient struggling with frequent or intense hot flashes, acupuncture may offer real, lasting relief without the need for additional medications. This study adds to a growing body of evidence supporting acupuncture as a safe complementary option during and after breast cancer treatment.

While larger studies are still needed to confirm long-term results, this research provides a solid reason to explore acupuncture as part of your care plan. Always look for a licensed, board-certified acupuncturist with experience working with oncology patients.

This randomized single-blind trial (n=47 analyzed; 27 TA, 20 SA) investigated traditional Chinese medicine-based acupuncture (TA) versus sham acupuncture (SA) for reducing hot flash (HF) severity in breast cancer patients reporting >10 HF episodes per week. Severity was assessed using the Menopause-specific Quality of Life (MenQoL) scale at baseline, post-treatment, and one-month follow-up. TA produced a statistically significant reduction in HF severity scores compared to SA (P=.0064), with a mean score decrease of 1.89 in the TA group versus 0.16 in the SA group — indicating a clinically meaningful effect size. Sustained response was observed at one-month follow-up in the TA cohort, while SA demonstrated no appreciable change. The near-zero response in the sham group strengthens the argument for specific therapeutic mechanisms beyond placebo. Clinically, this supports integrating TCM acupuncture into oncology supportive care protocols for HF management. Larger trials with extended follow-up are warranted.